Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections
SH Cheeseman, RH Rubin, JA Stewart, NE Tolkoff-Rubin, AB Cosimi, K Cantell, J Gilbert, S Winkle, JT Herrin, PH Black, PS Russell, and MS Hirsch
A double-blind, placebo-controlled trial of interferon prophylaxis against viral infections was conducted in renal-transplant recipients receiving standard immunosuprressive therapy with or without antithymocyte globulin. Interferon was administered for six weeks, beginning on the day of transplantation. Cytomegalovirus excretion began earlier and viremia was more frequent in placebo-treated than in interferon-treated patients. Cytomegalovirus viremia correlated with clinical syndromes was more frequent in recipients of antithymocyte globulin. In contrast, neither interferon nor antithymocyte globulin altered excretion of herpes simplex virus. Reversible leukopenia and thrombocytopenia occurred in seven interferon recipients. Patient and graft survival were comparable in interferon and placebo groups. There preliminary results suggest that a six-week course of prophylactic interferon delays shedding of cytomegalovirus and decreases the incidence of viremia after transplantation. In contrast, antithymocyte globulin appears to increase the severity of infection from cytomegalovirus among these patients.
This article has been cited by other articles:
Everly, M. J, Bloom, R. D, Tsai, D. E, Trofe, J.
(2007). Posttransplant Lymphoproliferative Disorder. The Annals of Pharmacotherapy
41: 1850-1858
[Abstract][Full Text]
Kvale, E. O., Dalgaard, J., Lund-Johansen, F., Rollag, H., Farkas, L., Midtvedt, K., Jahnsen, F. L., Brinchmann, J. E., Olweus, J.
(2006). CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood
107: 2022-2029
[Abstract][Full Text]
Griffiths, P. D.
(2002). The treatment of cytomegalovirus infection. J Antimicrob Chemother
49: 243-253
[Abstract][Full Text]
Afdhal, N. H., Yantiss, R. K.
(2001). Case 25-2001- A 71-Year-Old Man with Gastric Ulcers and Ileocecal Thickening Eight Years after Renal Transplantation. NEJM
345: 526-532
[Full Text]
(2000). Management of herpes virus infections following transplantation. J Antimicrob Chemother
45: 729-748
[Full Text]
Sia, I. G., Patel, R.
(2000). New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients. Clin. Microbiol. Rev.
13: 83-121
[Abstract][Full Text]
Miller, D. M., Zhang, Y., Rahill, B. M., Waldman, W. J., Sedmak, D. D.
(1999). Human Cytomegalovirus Inhibits IFN-{alpha}-Stimulated Antiviral and Immunoregulatory Responses by Blocking Multiple Levels of IFN-{alpha} Signal Transduction. J. Immunol.
162: 6107-6113
[Abstract][Full Text]
Conti, D. J., Freed, B. M., Singh, T. P., Gallichio, M., Gruber, S. A., Lempert, N.
(1995). Preemptive Ganciclovir Therapy in Cytomegalovirus-Seropositive Renal Transplants Recipients. Arch Surg
130: 1217-1222
[Abstract]
Stratta, R. J., Shaefer, M. S., Markin, R. S., Wood, R. P., Kennedy, E. M., Langnas, A. N., Reed, E. C., Woods, G. L., Donovan, J. P., Pillen, T. J., Duckworth, R. M., Shaw, B. W. Jr
(1989). Clinical Patterns of Cytomegalovirus Disease After Liver Transplantation. Arch Surg
124: 1443-1450
[Abstract]
Brayman, K. L., Dafoe, D. C., Smythe, W. R., Barker, C. F., Perloff, L. J., Naji, A., Fox, I. J., Grossman, R. A., Jorkasky, D. K., Starr, S. E., Friedman, H. M., Plotkin, S. A.
(1988). Prophylaxis of Serious Cytomegalovirus Infection in Renal Transplant Candidates Using Live Human Cytomegalovirus Vaccine: Interim Results of a Randomized Controlled Trial. Arch Surg
123: 1502-1508
[Abstract]
Hesse, U. J., Fryd, D. S., Chatterjee, S. N., Simmons, R. L., Sutherland, D. E. R., Najarian, J. S.
(1986). Pulmonary Infections: The Minnesota Randomized Prospective Trial of Cyclosporine vs Azathioprine-Antilymphocyte Globulin for Immunosuppression in Renal Allograft Recipients. Arch Surg
121: 1056-1060
[Abstract]
Haglund, S., Lundquist, P.-G., Cantell, K., Strander, H.
(1981). Interferon Therapy in Juvenile Laryngeal Papillomatosis. Arch Otolaryngol Head Neck Surg
107: 327-332
[Abstract]
